What is the role of alternate splicing in antigen presentation by major histocompatibility complex class I molecules?

被引:24
|
作者
Belicha-Villanueva, Alan [1 ]
Blickwedehl, Jennifer [1 ]
McEvoy, Sarah [1 ]
Golding, Michelle [1 ]
Gollnick, Sandra O. [1 ]
Bangia, Naveen [1 ]
机构
[1] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA
关键词
Antigen presentation; HLA antigens; Tapasin; Alternate splicing; MHC CLASS-I; BARE-LYMPHOCYTE-SYNDROME; PEPTIDE-LOADING COMPLEX; DEPENDENT REDUCTASE ERP57; DISULFIDE BOND FORMATION; HLA-B ANTIGENS; ENDOPLASMIC-RETICULUM; CELL-LINE; T-CELLS; OXIDOREDUCTASE ERP57;
D O I
10.1007/s12026-009-8123-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The expression of major histocompatibility complex (MHC) class I molecules on the cell surface is critical for recognition by cytotoxic T lymphocytes (CTL). This recognition event leads to destruction of cells displaying MHC class I-viral peptide complexes or cells displaying MHC class I-mutant peptide complexes. Before they can be transported to the cell surface, MHC class I molecules must associate with their peptide ligand in the endoplasmic reticulum (ER) of the cell. Within the ER, numerous proteins assist in the appropriate assembly and folding of MHC class I molecules. These include the heterodimeric transporter associated with antigen processing (TAP1 and TAP2), the heterodimeric chaperone-oxidoreductase complex of tapasin and ERp57 and the general ER chaperones calreticulin and calnexin. Each of these accessory proteins has a well-defined role in antigen presentation by MHC class I molecules. However, alternate splice forms of MHC class I heavy chains, TAP and tapasin, have been reported suggesting additional complexity to the picture of antigen presentation. Here, we review the importance of these different accessory proteins and the progress in our understanding of alternate splicing in antigen presentation.
引用
收藏
页码:32 / 44
页数:13
相关论文
共 50 条
  • [1] What is the role of alternate splicing in antigen presentation by major histocompatibility complex class I molecules?
    Alan Belicha-Villanueva
    Jennifer Blickwedehl
    Sarah McEvoy
    Michelle Golding
    Sandra O. Gollnick
    Naveen Bangia
    Immunologic Research, 2010, 46 : 32 - 44
  • [2] PRESENTATION OF AN EXOGENOUS ANTIGEN BY MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I MOLECULES
    ULMER, JB
    DONNELLY, JJ
    LIU, MA
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (07) : 1590 - 1596
  • [3] ANTIGEN PRESENTATION BY MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-B MOLECULES
    SHAWAR, SM
    VYAS, JM
    RODGERS, JR
    RICH, RR
    ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 : 839 - 880
  • [4] PRESENTATION OF EXOGENOUS ANTIGEN WITH CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX-MOLECULES
    ROCK, KL
    GAMBLE, S
    ROTHSTEIN, L
    SCIENCE, 1990, 249 (4971) : 918 - 921
  • [5] Proteolysis and class I major histocompatibility complex antigen presentation
    York, IA
    Goldberg, AL
    Mo, XY
    Rock, KL
    IMMUNOLOGICAL REVIEWS, 1999, 172 : 49 - 66
  • [6] Antigen processing and presentation by the class I major histocompatibility complex
    York, IA
    Rock, KL
    ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 : 369 - 396
  • [7] Enhancing major histocompatibility complex class I antigen presentation by targeting antigen to centrosomes
    Hung, CF
    Cheng, WF
    He, LM
    Ling, M
    Juang, J
    Lin, CT
    Wu, TC
    CANCER RESEARCH, 2003, 63 (10) : 2393 - 2398
  • [8] PEPTIDE PRESENTATION BY CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX-MOLECULES
    NIKOLICZUGIC, J
    CARBONE, FR
    IMMUNOLOGIC RESEARCH, 1991, 10 (01) : 54 - 65
  • [9] Major histocompatibility complex class I-restricted antigen processing and presentation
    Van Kaer, L
    TISSUE ANTIGENS, 2002, 60 (01): : 1 - 9
  • [10] Molecular mechanisms of class I major histocompatibility complex antigen processing and presentation
    Yang, Y
    Sempe, P
    Peterson, PA
    IMMUNOLOGIC RESEARCH, 1996, 15 (03) : 208 - 233